JSC National Atomic Company Kazatomprom NATKY · OTC
$63.01 +0.00% (+$0.00)
Summary
85 / 100 · Bulios Score
What speaks for it
- Out of every 100 KZT of revenue, 28 KZT is left as net profit.
- Earnings per share grew by 17% a year over the last 3 years.
- It earns 18 KZT a year on every 100 KZT of invested capital.
- It holds more cash than debt: 356.8B ₸ against 200.9B ₸.
What to watch
None of the indicators we track raises a caution right now.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 14.1 KZT for 1 KZT of yearly profit.
Valuation in detailIs it growing?
Yes, fastRevenue (KZT)
Diluted EPS (KZT)
- Analyst estimate
Revenue grew by 24% a year over 5 years. Over the last 3 years it grew by 21% a year. For the next fiscal year analysts expect revenue to grow by 28%. Earnings per share grew by 17% a year over the last 3 years.
Growth in detailDoes it make money?
Very wellWhere 100 KZT of revenue goes
- Cost of sales 54 KZT
- Research and development 0.2 KZT
- Sales and administration 4.1 KZT
- Taxes and other 13 KZT
- Net profit 28 KZT
Net profit, industry median (Uranium) 1.8 KZT
Out of every 100 KZT of revenue, 28 KZT is left as net profit.
Profitability in detailIs it financially healthy?
YesIt could repay all its debt from a single year of free cash flow. It holds more cash than debt.
Financial health in detailDoes it pay a dividend?
High, stretched- Yield
- 4.17%
- Paid out of profit
- 59%
You receive $2.63 per share a year. The payout takes a large part of its profit or free cash flow.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 1
- Hold 0
- Sell 0
Today's price within the analysts' price targets
The average target of $90 is 43% above today's price. 100% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.